NanoString to pay 10x Genomics $68m in global settlement

Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on sales of its spatial biology products.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

10x Genomics counsel: ‘Winning cases is a top priority’

22 October 2024 10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen.

Unified Patent Court

‘It was like starting all over again’: Tobias Wuttke

1 October 2024 Having been involved in more than 30 cases at the UPC, the Bardehle Pagenberg litigator tells Marisa Woutersen why success at the game-changing court is a team effort.

More features

Simmons & Simmons patent litigator jumps ship

ITC probes on the rise, but gender parity lags behind

IP agencies vital to pharma and biotech grind to a halt

USPTO trims workforce amid govt shutdown crisis

How impactful is the new USPTO director’s S101 decision?

Global vaccine patents rise, as data reveals shift in Big Pharma strategy

Philips wins unprecedented trade secret sanctions against Chinese defendants

Womble Bond Dickinson partners jump to rival firm

NanoString to pay 10x Genomics $68m in global settlement

More on this story

Editor's picks

Editor's picks

More features